Patient-specific t-SNE maps revealed non-glioblastoma populations of immune (CD45+) and endothelial (CD45-CD31+) cells, consistent with prior mass cytometry and sequencing studies of gliomas (Diggins et al., 2017; Greenplate et al., 2019; Leelatian et al., 2017a; Neftel et al., 2019; Patel et al., 2014). This evidence concerns the gene PECAM1 and glioma.